Inhibition of IKKB, a component of the IKK/NF-κB pathway, has been shown to improve obesity-induced insulin resistance and reduce TNF-α production in animal models (204, 205) and in T2D (137, 206, 207). This evidence concerns the gene TNF and Insulin resistance.